Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Chinese Patent Office
Citi
Colorcon
QuintilesIMS
Dow
Farmers Insurance
Boehringer Ingelheim
Medtronic
Fish and Richardson

Generated: April 26, 2018

DrugPatentWatch Database Preview

ERYTHROMYCIN LACTOBIONATE Drug Profile

« Back to Dashboard

When do Erythromycin Lactobionate patents expire, and when can generic versions of Erythromycin Lactobionate launch?

Erythromycin Lactobionate is a drug marketed by Abraxis Pharm, Baxter Hlthcare, and Teva Parenteral. and is included in three NDAs.

The generic ingredient in ERYTHROMYCIN LACTOBIONATE is erythromycin lactobionate. There are one hundred and two drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the erythromycin lactobionate profile page.
Drug patent expirations by year for ERYTHROMYCIN LACTOBIONATE
Synonyms for ERYTHROMYCIN LACTOBIONATE
1334-29-8
1334-39-0
33H58I7GLQ
3847-29-8
4-O-beta-D-Galactopyranosyl-D-gluconic acid compd. with erythromycin
4-O-beta-D-Galactopyranosyl-D-gluconic acid compd. with erythromycin (1:1)
847E298
AC1L2G7Z
AC1Q5R2M
Azithromycin lactobionate
C37H67NO13.C12H22O12
C49H89NO25
CA000798
CHEMBL1200506
CHEMBL3786307
D-Gluconic acid, 4-O-beta-D-galactopyranosyl-, compd. with erythromycin (1:1)
D-Gluconic acid, 4-O-beta-D-galactopyranosyl-, compd. with erythromycin (1:1) (9CI)
D02009
EINECS 223-348-7
Erythrocin Lactobionate IV
Erythromycin 4-O-beta-D-galactopyranosyl-D-gluconate (salt)
Erythromycin lactobionate (1:1) (salt)
Erythromycin lactobionate (JP17/USP)
Erythromycin lactobionate [JAN]
Erythromycin mono(4-O-beta-D-galactopyranosyl-D-gluconate) (salt)
Erythromycin, 4-O-beta-D-galactopyranosyl-D-gluconate (salt)
ERYTHROMYCIN; LACTOBIONIC ACID
Erythromycin. compd. with lactobionic acid
ERYTHROMYCINLACTOBIONATE
Lactobionic acid compd. with erythromycin (1:1)
Lactobionic acid, compd. with erythromycin (1:1)
LS-87509
MolPort-039-062-122
n-2,10-dion(1:1)
Q-201067
SCHEMBL41566
UNII-33H58I7GLQ

US Patents and Regulatory Information for ERYTHROMYCIN LACTOBIONATE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Abraxis Pharm ERYTHROMYCIN LACTOBIONATE erythromycin lactobionate INJECTABLE;INJECTION 062604-002 Nov 24, 1986 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Baxter Hlthcare ERYTHROMYCIN LACTOBIONATE erythromycin lactobionate INJECTABLE;INJECTION 062993-001 May 9, 1989 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Abraxis Pharm ERYTHROMYCIN LACTOBIONATE erythromycin lactobionate INJECTABLE;INJECTION 062604-001 Nov 24, 1986 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Baxter Hlthcare ERYTHROMYCIN LACTOBIONATE erythromycin lactobionate INJECTABLE;INJECTION 062993-002 May 9, 1989 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Daiichi Sankyo
Citi
Cipla
Healthtrust
Fuji
Deloitte
Teva
US Department of Justice
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.